|
Did the clinical trial use the Morisky? The Morisky Medication Adherence Scale is a simple and effective tool to address medication non-adherence in clinical trials. With an Internal Consistency
Cronbach's alpha .83, Sensitivity 93%, and Specificity 57%. It has been validated by clinicians and health professionals for different chronic conditions. It has been translated in over 90 languages. It can be administered electronically or at each office visit for long-term consistent evaluation. The MMAS-8 has undergone numerous levels of validation, including construct validation, discriminant validation, convergent validity with the MMAS scales, and the closest type of validation which mimics the "gold standard", criterion-related validity. The self-reported MMAS-8 agreed with physiological outcome measures such as BP control, HgA1c levels, GFR rates, HDL/LDL ratios, viral load levels, topical skin disorders, etc.
0 Comments
Leave a Reply. |
AuthorMarty Morisky, MS CSP CSHM Archives
September 2026
Categories Disclaimer: The information provided is for general information and education purposes only. It is not intended as, and should not be taken as, legal, medical, financial, professional , or any other form of advice. While we strive to keep the information accurate and up to date, we make no representations of warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability of the content. Any reliance you place on such information is strictly at your own risk. In no event will we be liable for any loss damage, including without limitation indirect or consequential loss or damage, arising out of or in connection with the use of the website/blog. Always seek the advice of a qualified professional for any specific questions or concerns. (7/20/2019) |
RSS Feed